These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 990371)

  • 1. The spectrum of pressor-response to norepinephrine in normotensive and hypertensive patients.
    London GM; Safar ME; Weiss YA; Simon A; Lehner JP; Milliez PL
    Biomedicine; 1976 Jun; 24(3):178-82. PubMed ID: 990371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects.
    Thijs L; Staessen JA; Celis H; Fagard R; De Cort P; de Gaudemaris R; Enström I; Imai Y; Julius S; Ménard J; Mion D; Palatini P; Rosenfeld J; Shapiro D; Spence D; Stergiou G
    Blood Press Monit; 1999 Apr; 4(2):77-86. PubMed ID: 10450117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efflux of nor-epinephrine from platelets in essential hypertension.
    Chandra N; Chandra M; Pandeya SN; Dhawan S; Soni D
    Indian Heart J; 1991; 43(6):461-3. PubMed ID: 1823895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database.
    Staessen JA; O'Brien ET; Amery AK; Atkins N; Baumgart P; De Cort P; Degaute JP; Dolenc P; De Gaudemaris R; Enström I
    J Hypertens Suppl; 1994; 12(7):S1-12. PubMed ID: 7769499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. The Ad-Hoc Working Group.
    Staessen JA; O'Brien ET; Atkins N; Amery AK
    J Hypertens; 1993 Nov; 11(11):1289-97. PubMed ID: 8301112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body sodium blood volume state in essential hypertension: abnormal relation of exchangeable sodium to age and blood pressure in male patients.
    Beretta-Piccoli C; Weidmann P; Brown JJ; Davies DL; Lever AF; Robertson JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S134-42. PubMed ID: 6204132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced pressor responses to experimental and daily-life stress in borderline hypertension.
    Jern S; Bergbrant A; Hedner T; Hansson L
    J Hypertens; 1995 Jan; 13(1):69-79. PubMed ID: 7759855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure sensitivity to salt, calcium metabolism and insulin sensitivity in essential hypertension.
    Saruta T; Tominaga T; Yamakawa H; Ohno Y; Suzuki H
    Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):S406-11. PubMed ID: 8846505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of cardiovascular hypersensitivity to norepinephrine by potassium supplementation in normotensive members of hypertensive families and patients with essential hypertension.
    Bianchetti MG; Beretta-Piccoli C; Weidmann P; Ferrier C; Link L; Gerber A
    J Hypertens Suppl; 1984 Dec; 2(3):S445-8. PubMed ID: 6599696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
    González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
    Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
    Ito O; Okamoto M; Murakami Y; Nakayama R
    J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute water ingestion increases arterial blood pressure in hypertensive and normotensive subjects.
    Callegaro CC; Moraes RS; Negrão CE; Trombetta IC; Rondon MU; Teixeira MS; Silva SC; Ferlin EL; Krieger EM; Ribeiro JP
    J Hum Hypertens; 2007 Jul; 21(7):564-70. PubMed ID: 17344908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
    Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Favre L; Vallotton M
    J Hypertens Suppl; 1986 Dec; 4(6):S310-3. PubMed ID: 3475419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.